Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

Fecal Microbiota Transplantation 2Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Solid Carcinoma × Clear all
NCT04264975 2026-05-22

Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

Asan Medical Center

Phase NA Recruiting
60 enrolled

Solid Carcinoma

NCT06051214 2026-02-17

THROMBIN

Institut Cancerologie de l'Ouest

Phase NA Recruiting
200 enrolled

Solid Carcinoma

NCT05533983 2025-12-03

NIVO-FMT

Asan Medical Center

Phase NA Recruiting
50 enrolled

Solid Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡